My Account

Friday, March 24, 2023

Canada’s Politics and Government News Source Since 1989

Proposed PMPRB regulations requires focused dialogue with all players

Canada needs an approach that balances pricing considerations with the need to encourage investment, foster innovation, and most of all, ensures Canadians have timely access to the most innovative, life-saving new medicines.

Opinion
BY PAMELA FRALICK
February 17, 2022

Opinion | BY PAMELA FRALICK | February 17, 2022

See all stories BY PAMELA FRALICK

More Opinion

Liberals have a theory for winning

OpinionBY GERRY NICHOLLS

Despite global pledge to combat Islamophobia, systemic anti-Muslim hate is on the rise

OpinionBY TAHA GHAYYUR, FAREED KHAN

How to secure Canada’s low-carbon advantage in the global clean energy race

OpinionBY MICHAEL BERNSTEIN, BENTLEY ALLAN

Economic reconciliation and Inuit self-determination must see funding in Budget 2023

OpinionBY KONO TATTUINEE, DAVID KAKUKTINNIQ, ANNE-RAPHAëLLE AUDOUIN

MPs’ work on gun control misses target

OpinionBY SUZANNE ZACCOUR, ERIN WHITMORE, PAULETTE SENIOR

Is drug price policy evidence-based or evidence-deficient?

OpinionBY BRETT SKINNER

New drug pricing rules on Canada Day will end years of damaging uncertainty for industry and patients

OpinionBY JASON FIELD

Will the government stop the changes to PMPRB?

OpinionBY DOUG EARLE

Ottawa’s next steps on life sciences a turning point for health system, economic and societal recovery from COVID-19

OpinionBY JASON FIELD

PMPRB’s new regulations could be Canada’s monkey’s paw

Opinion

Proposed PMPRB regulations requires focused dialogue with all players

Canada needs an approach that balances pricing considerations with the need to encourage investment, foster innovation, and most of all, ensures Canadians have timely access to the most innovative, life-saving new medicines.

Preparing our medical system for the next pandemic

Canada must renew leadership on antimicrobial resistance

Ongoing uncertainty about prices will deter new drug launches in Canada

Preparing our medical system for the next pandemic

Real People. Real Stories.

Liberals have a theory for winning

Despite global pledge to combat Islamophobia, systemic anti-Muslim hate is on the rise

How to secure Canada’s low-carbon advantage in the global clean energy race

Economic reconciliation and Inuit self-determination must see funding in Budget 2023

MPs’ work on gun control misses target

Is drug price policy evidence-based or evidence-deficient?

New drug pricing rules on Canada Day will end years of damaging uncertainty for industry and patients

Will the government stop the changes to PMPRB?

Ottawa’s next steps on life sciences a turning point for health system, economic and societal recovery from COVID-19

PMPRB’s new regulations could be Canada’s monkey’s paw

News

Get free news updates

Opinion

Submit a guest opinion article

resources

Advertise

subscribe

get help

Proposed PMPRB regulations requires focused dialogue with all players

Canada needs an approach that balances pricing considerations with the need to encourage investment, foster innovation, and most of all, ensures Canadians have timely access to the most innovative, life-saving new medicines.

Get The Weekend Point of View Newsletter